The importance of early diagnosis in Alzheimer's disease and mild cognitive impairment
Confirming a diagnosis of mild cognitive impairment (MCI) and Alzheimer’s disease (AD) is important and often a relief for the individual and their loved ones. Receiving a diagnosis early enables patients to make changes to their diet and lifestyles which may slow the decline in their cognitive functions.1
Transforming disparate data into actionable insights for better clinical and business decision-making
The future of healthcare is filled with uncertainty, making an efficient laboratory invaluable. What if labs could consolidate and automate more than 90%* of routine testing? The Molecular Work Area can elevate the value your laboratory delivers with automation, consolidation, integration, and standardization.
Innovation made accessible
Based on Roche's Molecular Work Area concept, the cobas® 5800 System enables laboratories to transform their approach to molecular testing. This concept now comes in a compact size, delivering premium performance and value-added utility from a small footprint.
The newest member of the cobas® family of systems
cobas® pure is the new system combining clinical chemistry, immunochemistry and ISE testing on a footprint of just 2sm, giving access to our broad menu of parameters – including many unique high medical value assays to labs who have to deal with limited space.